Microchip Technology Inc. vs Medpace Holdings Inc — how do they compare? Microchip Technology Inc. trades at $83.25 (market cap $43.72B), while Medpace Holdings Inc trades at $530.22 (market cap $15.08B). The key difference: Microchip Technology Inc. is far larger — about 2.9× Medpace Holdings Inc's market cap, and Microchip Technology Inc. pays a 2.26% dividend while Medpace Holdings Inc pays none. Which is the better fit depends on your goals.
| MCHP | MEDP | |
|---|---|---|
Market Cap | $43.72B | $15.08B |
Sector | Technology | Technology |
52-Week High | $102.97 | $620.59 |
52-Week Low | $49.02 | $308.88 |
Enterprise Value | $49.01B | $14.55B |
Dividend Yield | 2.26% | — |
Trailing returns across standard periods
Latest headlines on both assets
Microchip became an independent company in 1989 when it was spun off from General Instrument. More than half of revenue comes from MCUs, which are used in a wide array of electronic devices from remote controls to garage door openers to power windows in autos. The company's strength lies in lower-end 8-bit MCUs that are suitable for a wider range of less technologically advanced devices, but the firm has expanded its presence in higher-end MCUs and analog chips as well.
Read more on MCHP →Medpace Holdings, Inc. is a full-service clinical contract research organization (CRO) that provides comprehensive and scientifically-driven clinical development services to the biotechnology, pharmaceutical, and medical device industries. The company specializes in conducting global clinical trials for new drug and medical device approvals. Medpace's model emphasizes therapeutic expertise and a highly integrated approach to accelerate the clinical development process for its clients.
Read more on MEDP →